Video

ELEVECTA™ Producer Cell Line For Transfection-Free AAV Manufacturing

Source: Cytiva

Embrace the future of gene therapies with the ELEVECTA™ producer cell line. Overcoming challenges in large-scale viral vector manufacturing, such as batch variability from transient transfection, the ELEVECTA™ producer cell line offers a solution with all its components stably integrated. Production is initiated by simply adding an induction reagent. This straightforward, one-step process guarantees robustness and scalability for your gene therapy endeavors.

access the Video!

Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Biosimilar Development? Subscribe today.

Subscribe to Biosimilar Development X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Biosimilar Development

Please tell us more about you so that we can customize our newsletters to your specific interests:

Cytiva